Next Article in Journal
Possible Role of Correlation Coefficients and Network Analysis of Multiple Intracellular Proteins in Blood Cells of Patients with Bipolar Disorder in Studying the Mechanism of Lithium Responsiveness: A Proof-Concept Study
Previous Article in Journal
Determination of Serum Arginase-1 Concentrations and Serum Arginase Activity for the Non-Invasive Diagnosis of Endometriosis
Previous Article in Special Issue
Impact of the Order of Movement on the Median Nerve Root Function: A Neurophysiological Study with Implications for Neurodynamic Exercise Sequencing
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Effect of Mirror Therapy on Post-Needling Pain Following Deep Dry Needling of Myofascial Trigger Point in Lateral Elbow Pain: Prospective Controlled Pilot Trial

by
Sebastián Eustaquio Martín Pérez
1,2,3,4,*,
Jhoselyn Delgado Rodríguez
1,
Alejandro Kalitovics
1,
Pablo de Miguel Rodríguez
1,
Daniela Sabrina Bortolussi Cegarra
2,
Iremar Rodríguez Villanueva
2,
Álvaro García Molina
2,
Iván Ruiz Rodríguez
2,
Juan Montaño Ocaña
2,
Isidro Miguel Martín Pérez
3,4,*,
María Dolores Sosa Reina
2,5,
Jorge Hugo Villafañe
2,5 and
José Luis Alonso Pérez
1,2,5
1
Musculoskeletal Pain and Motor Control Research Group, Faculty of Health Sciences, Universidad Europea de Canarias, 38300 Santa Cruz de Tenerife, Spain
2
Musculoskeletal Pain and Motor Control Research Group, Faculty of Sport Sciences, Universidad Europea de Madrid, Villaviciosa de Odón, 28670 Madrid, Spain
3
Departamento de Medicina Física y Farmacología, Área de Radiología y Medicina Física, Facultad de Ciencias de la Salud, Universidad de la Laguna, 38200 Santa Cruz de Tenerife, Spain
4
Escuela de Doctorado y Estudios de Posgrado, Universidad de La Laguna, 38200 Santa Cruz de Tenerife, Spain
5
Department of Physiotherapy, Faculty of Sport Sciences, Universidad Europea de Madrid, Villaviciosa de Odón, 28670 Madrid, Spain
*
Authors to whom correspondence should be addressed.
J. Clin. Med. 2024, 13(5), 1490; https://doi.org/10.3390/jcm13051490
Submission received: 1 February 2024 / Revised: 26 February 2024 / Accepted: 28 February 2024 / Published: 5 March 2024
(This article belongs to the Special Issue Musculoskeletal Disorders: Clinical Rehabilitation and Physiotherapy)

Abstract

:
Background: This prospective randomized, controlled pilot trial to explore the immediate effect of adding Mirror Visual Feedback Therapy on pain sensitivity and motor performance among subjects suffering from post-needling pain diagnosed as Lateral Elbow Pain. Methods: A total of 49 participants (23 female, 26 male) were enrolled and randomly allocated to either the experimental group, which received Deep Dry Needling in the m. Brachioradialis, Ischemic Compression, Cold Spray, Stretching, and Mirror Visual Feedback Therapy (n = 25), or a control group without Mirror Visual Feedback Therapy (n = 24). Pre- and post-treatment evaluations included assessments of post-needling pain intensity, pressure pain threshold, two-point discrimination threshold, and maximum hand grip strength. Results: Intergroup analysis revealed a statistically significant reduction in post-needling pain intensity favoring the experimental group (U = 188.00, p = 0.034). Additionally, intragroup analysis showed significant improvements in post-needling pain intensity (MD = 0.400, SEM = 0.271, W = 137.00, p = 0.047) and pressure pain threshold (MD = 0.148 Kg/cm2, SEM = 0.038, W = 262.00, p < 0.001) within the experimental group following the intervention. Conclusions: These findings suggest a potential benefit of integrating Mirror Visual Feedback Therapy into treatment protocols for individuals with Lateral Elbow Pain experiencing post-needling discomfort. Further research is necessary to fully elucidate the clinical implications of these findings.

1. Introduction

Lateral Elbow Pain, affecting 1–3% of the population annually, is a common musculoskeletal disorder primarily associated with occupational activities and repetitive biomechanical stress on the joints, including the intricate support systems within the hand and wrist [1,2]. Myofascial pain syndrome (MPS) emerges as a significant etiological factor in Lateral Elbow Pain, characterized by the presence of hyperirritable and taut bands within extensor muscles, known as myofascial trigger points (MTrPs), which can lead to local pain and regional sensory abnormalities [3,4].
These symptoms may arise from the activation of sensory–motor pathways within the spinal cord and brainstem by MTrPs [5], leading to the involvement of reflex circuits that induce local spastic responses, referred pain, and motor dysfunction in individuals diagnosed with MPS [6,7,8,9,10]. Additionally, there is a suggested association between sensory abnormalities and peripheral sensitization triggered by active muscle nociceptors [11,12,13]. Consequently, the persistent activation of these nociceptors is thought to contribute to the progression of central sensitization (CS) [14]. Although the exact mechanism remains elusive, recent studies have implicated ionotropic acid-sensing ion channels (ASIC), specifically ASIC-1 and ASIC-3, in the development of CS [15]. These channels play distinct roles in primary and secondary hyperalgesia, indicating their potential involvement in facilitating the transition from peripheral to central sensitization [16].
Conservative approaches such as Deep Dry Needling (DDN) have demonstrated effectiveness in reducing hyperalgesia and alleviating sensory–motor disturbances [17,18]. This technique involves rhythmic transcutaneous needling of the affected muscles or MTrPs without the use of injectable substances [19]. Recent studies examining biopsies from animal models post Deep Dry Needling (DDN) have shown an increase in the release of neurotransmitters and proinflammatory substances in the punctured area. These include endogenous opioids, which inhibit pain transmission [20], and a reduction in substances such as bradykinin, substance P, CGRP, TNF, IL-1β, serotonin, and norepinephrine [21,22,23]. Additionally, pH increases in the MTrPs region deactivate acid-sensing ion channels, potentially reducing mechanical hyperalgesia and limiting CS onset [24].
Nevertheless, in human models, it is commonly observed that pain arises as an iatrogenic complication subsequent to puncture procedures, often referred to as post-needling pain. Its incidence is typically estimated to range from 29.4% to 100% in most studies and it usually arises immediately following the procedure and diminishes within 72 h [25,26,27], a timeframe that can be attributed to the immediate release of algogenic substances triggering an inflammatory response and neuromuscular damage caused by the needle [28]. This primary peripheral tissue sensitization that arises from dysfunctional sensory signals at the puncture site, compounded by spinal dysregulation, could cause heightened pain signal transmission to the central nervous system (CNS). Moreover, spinal dysregulation can result in heightened nociceptor activity, deterioration of C-fibers, depletion of A-fibers, adverse modulation of GABAergic activity, and opioid receptors, expanded receptive fields in deafferented areas, and spinal cord hyperexcitability due to modified substance P expression by Aß fibers [29,30]. This may elucidate the pronociceptive effect experienced by patients following treatment with DDN.
For its management, the gold standard involves maneuvers of Ischemic Compression (IC) combined with Cold Spray with Stretching (STR) because of their efficacy in controlling blood perfusion, oxygen and nutrient supply, and activation of endogenous analgesic mechanisms [31,32]. However, the analgesic therapeutic effects achieved through the aforementioned procedure could be further augmented by stimulating supramedullary centers responsible for processing observational and movement execution. In this context, Mirror Visual Feedback Therapy (MVF) emerges as an effective, safer, and cost-efficient technique for activating brain areas associated with the mesolimbic system and the somatosensory cortex [33,34]. These areas play a crucial role in generating perceptual illusions [35] and recalibrating sensory–motor integration [36], potentially leading to a reduction in nociceptive pain and sensory–motor functional impairment after DDN [37,38,39].
While MVF has demonstrated promise in mitigating pain and reinstating voluntary motor functions among patients diagnosed with stroke [40] or phantom limb syndrome [41,42], its immediate effects in managing post-needling pain have not yet been explored in the literature. Due to the lack of comparable research examining and elucidating the immediate physiological impact of integrating MVF with the gold standard treatment following DDN, this pilot study aims to explore the immediate effect of adding MVF on pain sensitivity and motor performance among subjects suffering from post-needling pain diagnosed as Lateral Elbow Pain.

2. Materials and Methods

2.1. Study Design

A prospective randomized, controlled, two-arm pilot trial was conducted between 1 February 2023 and 2 June 2023, rigorously adhering to the Consolidated Standards of Reporting Trials standard (CONSORT) [43] (Table S1). The study was conducted in compliance with the principles outlined in the Declaration of Helsinki and received approval from the Ethics Committee of Hospital Clínico San Carlos in Madrid, Spain (approval number 23/107-EC X TFM, dated 7 March 2023). Additionally, the study was prospectively registered on ClinicalTrials.gov with the identifier NCT06288048. The study protocol was developed by researchers D.S.B.C., I.R.V., and A.G.M.; A.K., J.D.R., and P.d.M.R. were responsible for administering written informed consent, intervention and assessments. Participant selection is described below in Figure 1, in a CONSORT Flow Diagram.

2.2. Participants

Participants were recruited through consecutive non-probabilistic sampling from 20 February 2023 to 1 June 2023. The recruitment strategy employed a multifaceted approach, which included word-of-mouth referrals from both physical therapy and general practitioner (GP) consultations, outreach through social media platforms, posting notices on bulletin boards, and leveraging existing researcher networks. The inclusion criteria were established as follows:
(1) Males and females aged 18 years or older, (2) suffering from lateral elbow myofascial pain diagnosed by either a GP or physical therapist (3) for a duration of less than 3 months, (4) lacking a history of severe trauma, (5) having no prior exposure to Dry Needling treatment, (6) not currently using relevant medications, (7) having no history of musculoskeletal surgeries and (8) no documented toxic habits.
All participants provided written consent prior to participating in the study.

2.3. Sample Size Determination

The G*Power 3.1 software was utilized for the computation of sample size and power [44]. The estimations were based on a minimal clinically important difference (MCID) in the Visual Analog Scale (VAS) of 30 mm established for healthy subjects [45]. Assuming a confidence interval (CI) of −36.4 to −23.6, a two-tailed test, an alpha level of 0.05, and a desired power of 80%, the estimated sample size for each arm was 23 individuals.

2.4. Randomized Allocation

Participants were randomly allocated to either the intervention or control groups using a number sequence generated by an independent researcher. The randomization process was conducted using a random sequence generator available at Random.org (http://www.random.org (accessed on 1 April 2023). Allocation concealment was appropriately maintained throughout the study.

2.5. Intervention

The intervention was conducted in the simulated hospital consultation room at the European University (Madrid, Spain) during a single 1 h long session. Prior to the intervention, the practitioner responsible for administering the treatment, possessing over 10 years of clinical experience, conducted an interview to validate the inclusion criteria. Furthermore, clinical assessment maneuvers, including flat and pincer palpation, were carried out on the elbow extensor muscles to identify regions of augmented mechanical hyperalgesia corresponding to m. Brachioradialis (BR) MTrP patient symptoms. Afterwards, when obtaining informed consent, clear and consistent instructions regarding treatment efficacy were provided to both groups. Subsequently, participants were randomly allocated according to blinded sequence into two distinct treatment groups.
Experimental group: Deep Dry Needling (DDN), Ischemic Compression, Cold Spray with Stretching + MVF.
The DDN intervention targeted the proximal third of the m. Brachioradialis (BR) with the patient seated, and the therapist positioned on the same side as the needle insertion. Dry Needling involved a lateral-to-medial needle insertion direction toward the clinician’s finger, with a precision grip. In lean patients, precautions were taken to avoid accidental finger puncture by inserting the needle between the clinician’s fingers. DDN was performed with needle (AguPunt®, Barcelona, Spain) seeking three local twitch responses in m. Brachioradialis (BR). For subjects without such responses, 10 needle insertions and withdrawals at a frequency of 1 Hz were performed.
Following needling, Ischemic Compression (IC) was applied using a sphygmomanometer on the seated subject’s arm. Pressure was increased until ischemic pain appeared (approximately 200 mmHg), maintained for 90 s. This was combined with three applications of Cold Spray (Cryos Phyto Performance 400 mL) from origin to insertion, synchronized with m. Brachioradialis (BR) stretching consisting of passive sustained mobilization with elbow extension and forearm pronation for 10 s.
The intervention concluded with Mirror Visual Feedback Therapy (MVF). The patient was seated with forearms resting on the bed, facing a 35 × 35 cm mirror (Mirror Therapy Box, Reflex Pain Management Ltd®, Stockport, UK) covering the punctured side at a 45-degree angle for proper hand visualization. The punctured limb was positioned behind the mirror, out of the subject’s view. Any identifying objects (rings, bracelets, etc.) on the healthy limb were removed or covered. The MVF protocol consisted of two phases, each lasting 20 min. In the first phase, the therapist performed hand exercises while the subject observed the therapist’s hand reflected in the mirror. In the second phase, the subject executed hand opening and closing and wrist extension and flexion movements while observing their hand in the mirror. All movements were conducted at a frequency of 1 Hz with 40 repetitions.
Control group: Deep Dry Needling (DDN), Ischemic Compression, Cold Spray with Stretching.
Group 2 underwent Deep Dry Needling (DDN), Ischemic Compression, Cold Spray, and Stretching. Notably, this group did not undergo MVF. See details below, in Figure 2 and Figure 3.

2.6. Outcome Measures

The assessments encompassed pain intensity (VAS), pain pressure threshold (Wagner™ FPX Algometer 50, Greenwich, CT, USA), two-point discrimination threshold (Baseline® 12-1480 skin caliper, 2-point discriminator, White Plains, NY, USA), and maximum hand grip strength (JAMAR® Hand Dynamometer J00105, Bolingbrook, IL, USA). Measurements were documented both before starting the intervention and within 5 min after concluding the treatment for pre- and post-intervention assessments. All outcomes were evaluated by an assessor blinded to the treatment allocation of the subjects.

2.7. Statistical Analysis

Descriptive statistics were computed, encompassing measures of central tendency and dispersion parameters. To assess the normality of the data, the Shapiro–Wilk test was systematically applied to all study variables. Following the verification of data normality, intra-group variations were quantified utilizing the Wilcoxon signed-rank test, while inter-group differences were appraised through the Mann–Whitney U test. Subsequently, the calculation of effect size was performed using the point–biserial correlation coefficient. All statistical analyses were executed with the SPSS 26.0 software (IBM Corp.®, Armonk, NY, USA). Significance was established considering p-values below 0.05 as indicative of statistical significance.

3. Results

3.1. Demographic Description of the Sample

A total of 49 participants (F = 23, M = 26) were selected, with an average age of 24.9 (10.9) in the EG (n = 25) and 24.9 (9.5) years in the CG (n = 24). The mean weight of participants was 75.8 (5.7) Kg for the EG and 73.3 (10.5) Kg for the CG. Regarding height, the EG had a slightly higher stature at 1.77 (0.06) m compared to the CG at 1.72 (0.08) m. The body mass index (BMI) was very similar between the two groups, with values of 24.2 (1.7) and 24.7 (3.5), respectively. No statistically significant differences were identified between the two experiment groups. Further details can be found in Table 1.

3.2. Description of Study Variables

In terms of pre- and post-needling pain intensity (VAS 0-10), the experimental group showed a mean of 1.416 and 1.064, respectively, with the control group showing values of 1.150 and 1.633. PPT (Kg/cm2) indicated mean values of 1.485 Kg/cm2 (pre) and 1.77 Kg/cm2 (post) for the experimental group, and 1.843 Kg/cm2 (pre) and 1.72 Kg/cm2 (post) for the control group. Additionally, Two-point discrimination thresholds (TPDT) in millimeters revealed pre-values of 12.3 mm (EG) and 12.7 mm (CG), with post-values of 13.5 mm and 13.7 mm, respectively. Maximum hand grip strength (MHGS) displayed pre-values of 37.96 Kg/F for EG and 34.04 Kg/F in CG, while post-values were 37.712 Kg/F and 34.867 Kg/F. Due to the presence of violations of normality assumptions, a decision was made to employ non-parametric analysis for examining intra-group and inter-group differences in the study. More details are in Table 2.

3.3. Main Findings

3.3.1. Intra-Group Differences

Experimental group: Deep Dry Needling (DDN), Ischemic Compression, Cold Spray with Stretching + MVF.
Post-needling pain intensity in participants of the experimental group (EG) showed statistically significant findings (MD = 0.400, SEM = 0.271, W = 137.00, p = 0.047) immediately after the addition of MVF to the DDN protocol. Similarly, the pressure pain threshold (PPT) demonstrated significant results (MD = 0.148 Kg/cm2, SEM = 0.271, W = 262.00, p < 0.001). In contrast, the two-point discrimination threshold (TPDT) (MD = −0.000 mm, SEM = 0.674, W = 121.00, p = 0.711) and maximum hand grip strength (MHGS) (MD = 0.200 Kg/F, SEM = 0.1999, W = 177.00, p = 0.224) did not exhibit statistically significant differences between initial and post-treatment measurements. Intra-group differences of the experimental group are detailed in Table 3.
Control group: Deep Dry Needling (DDN), Ischemic Compression, Cold Spray with Stretching.
Post-needling pain intensity in participants assigned to the control group (CG), as assessed by the Visual Analog Scale (VAS 0-10), did not reveal statistically significant differences (MD = −0.400, SEM = 0.247, W = 105.50, p = 0.643). Similarly, the pressure pain threshold (PPT) displayed non-significant results (MD = 0.029 Kg/cm2, SEM = 0.073, W = 163.00, p = 0.648), as did the two-point discrimination threshold (TPDT) (MD = 1.999 mm, SEM = 1.047, W = 207.00, p = 0.983) following 5 min of control intervention. Conversely, in the case of maximum hand grip strength (MHGS), there was a notable trend toward improvement in the CG, although without reaching statistical significance (MD = −0.799 Kg/F, SEM = 1.051, W = 83.00, p = 0.081). Intra-group differences of control group are displayed in detail in Table 4.

3.3.2. Inter-Group Differences

There was a statistically significant reduction in post-needling pain intensity (VAS 0-10) (U = 188.00, p = 0.034) suggesting a meaningful shift towards lower pain levels in individuals of EG treated with MVF with those who were not (CG) for managing post-needling pain. Furthermore, post-TPDT (mm) exhibited a trend towards significance (U = 212.00, p = 0.079), signifying a notable group difference and a substantial reduction in values among participants assigned to the EG. In contrast, post-PPT (Kg/cm2) and post-MHGS (Kg/F) values showed non-significant distinctions between groups (U = 354.00, p = 0.862; U = 365.0, p = 0.905, respectively). Detailed explanations of intergroup differences are provided in Table 5 and visually depicted in Figure 4.

4. Discussion

The addition of Mirror Visual Feedback Therapy (MVF) after Dry Needling (DDN) in patients experiencing post-needling pain from myofascial trigger points (MTrPs) in Lateral Elbow Pain has shown promise in reducing pain and enhancing sensitivity in patients with Lateral Elbow Pain. The study’s findings revealing a statistically significant reduction in post-needling pain intensity within the experimental group (EG) receiving MVF compared to the control group (CG) not only underscores the potential efficacy of MVF, but also suggests its utility in managing acute pain associated with DDN in MTrP patients.
This convergence of results with prior research emphasizes the role of visual feedback mechanisms in pain modulation and the improvement of sensory function across a spectrum of musculoskeletal disorders [46,47]. Indeed, current theories support the notion that visualizing symmetrical movements through a mirror may influence sensory perception and modulate neuronal activity associated with pain sensation [48].
Firstly, this could be explained due to MVF showing the activation of mirror neuron systems which facilitate ipsilateral primary motor cortex (M1) excitability [49,50]. Furthermore, increased corticospinal excitability of the M1 has been observed to be associated with more efficient inhibitory pain modulation assessed by CPM [51]. In MPS, such as in our patients, M1 excitability exhibits characteristics such as reduced cortical silent period, decreased short-interval intracortical inhibition, and heightened intracortical facilitation and motor-evoked potentials [52]. Based on our findings, MVF appears to hold promise in diminishing corticospinal excitability, which encompasses resting motor threshold, MEPs, and cortical silent period [53].
Secondly, an alternative hypothesis explaining the immediate relief from pain and increasing mechanical threshold involves the influence of Distraction and Attentional Modulation [54,55,56,57]. The visual feedback provided by MVF can act as a distracting element, diverting the patient’s attention away from the sensation of pain [33]. Recent research suggests that the perception of the illusion triggers activation in the motor cortex by providing strong visual feedback that movements are occurring naturally and without hindrance. Moreover, this visual illusion enhances activity in the primary motor cortex (M1) through a top–down effect on the ipsilateral premotor cortex, thereby facilitating increased neuroplasticity [58]. Additionally, mirror-induced visual illusions stimulate various brain regions including the fronto-temporo-parietal, occipital, and cerebellar areas, which play crucial roles in movement sequencing and coordination [59,60]. Overall, this phenomenon of attentional input disruptions can amplify the body’s natural pain-inhibitory mechanisms, potentially engaging both supraspinal systems and descending pathways that regulate the transmission of nociceptive signals at the spinal cord level [61].
Thirdly, expectation and conditioning effects may explain the immediate decrease in pain and significant improvements observed in the pressure pain threshold (PPT) within the EG. In this regard, repeated exposure to the visual illusion of pain-free movement during an MVF session may lead to the formation of positive associations between movement and reduced pain [62,63]. This can be supported with the fact that observation of a movement in a safe context can be attributed to the reduced activation of cortical regions associated with spatial localization of body parts, such as the superior parietal lobule [64], working memory and sensorimotor processing, superior frontal gyrus [65], and notably mesolimbic areas linked to emotions like the insular cortex responsible for the sense of agency [65,66]. Research on psycho-physiological interactions has illustrated the functional connections between the anterior insula and the amygdala [67], as well as the interplay between the insula and the dorsomedial frontal cortex involved in intentional movement generation [60,68,69]. This might adequately decrease the amygdala’s sensitivity in models experiencing nociceptive pain, thus diminishing the effects of catastrophizing and fear of movement commonly felt immediately after undergoing Dry Needling.
Finally, it has been demonstrated that MVF induces cortical reorganization by promoting the formation of new neuronal connections and modifying existing neuronal networks [39,70,71]. However, despite this, we rule out the possibility that the positive effects observed in our experiment are due to this mechanism. In fact, the characteristics of our design do not allow us to ascertain the neuroplastic changes that would occur, presumably, with long-term exposure to MVF.

Limitations

Despite the promising results, this pilot study presents certain limitations that should be considered when interpreting the findings. These limitations include the relatively small sample size and the lack of long-term follow-up to assess the durability of observed MVF effects. Additionally, heterogeneity in pain severity and duration among participants could have influenced the results and may limit the generalizability of findings to a broader population of post-needling pain patients.
To advance the understanding of immediate MVF effects on post-needling pain and sensory function in lateral elbow myofascial pain patients, future research exploring different treatment protocols is warranted. This includes variations in the duration and frequency of MVF sessions, as well as the incorporation of additional outcome measures such as motor function and health-related quality of life. Furthermore, longitudinal studies with larger participant cohorts and long-term follow-up are needed to evaluate the efficacy and durability of MVF effects in managing post-needling pain across diverse clinical populations. These forthcoming studies will contribute to refining and enriching the application of MVF in clinical settings for addressing iatrogenic nociceptive pain, not only in relation to DDN but also other techniques where counterirritants, such as Dry Needling for MTrPs in the lateral elbow, play a significant role in immediate analgesic responses.

5. Conclusions

MVF reduced post-needling pain and influenced sensory perception with MTrPs in Lateral Elbow Pain patients. The significant pain reduction and notable trend in sensory discrimination imply positive effects of MVF. These results underscore the necessity for a more comprehensive mechanistic understanding and highlight MVF’s potential as an adjunctive intervention in managing myofascial pain.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/jcm13051490/s1, Table S1: CONSORT 2010 checklist of information to include when reporting a randomized trial.

Author Contributions

Conceptualization, I.R.R., M.D.S.R. and J.M.O.; methodology, S.E.M.P.; software, I.M.M.P.; validation, J.L.A.P.; formal analysis, S.E.M.P. and I.M.M.P.; investigation, D.S.B.C.; resources, I.R.V.; data curation, Á.G.M.; writing—original draft preparation, J.D.R., A.K. and P.d.M.R.; writing—review and editing, S.E.M.P.; visualization, I.M.M.P., M.D.S.R. and J.H.V.; supervision, J.L.A.P. and J.H.V.; project administration, J.L.A.P.; funding acquisition, J.L.A.P. All authors have read and agreed to the published version of the manuscript.

Funding

The research received financial supported from the European University of the Canary Islands, located at C/Inocencio García 1, 38300 La Orotava, Tenerife, 38300 Canary Islands, Spain.

Institutional Review Board Statement

The study was conducted according to the guidelines of the Declaration of Helsinki and approved by the Ethics Committee of Hospital Clínico San Carlos (23/107-EC X TFM, 7 March 2023) and registered prospectively on Clinicaltrial.gov (NCT06288048).

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

Data will be available on demand.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Martín-Pintado-Zugasti, A.; Pecos-Martin, D.; Rodríguez-Fernández, Á.L.; Alguacil-Diego, I.M.; Portillo-Aceituno, A.; Gallego-Izquierdo, T.; Fernandez-Carnero, J. Ischemic Compression After Dry Needling of a Latent Myofascial Trigger Point Reduces Post-Needling Soreness Intensity and Duration. PM&R 2015, 7, 1026–1034. [Google Scholar] [CrossRef]
  2. Dommerholt, J. Dry needling–peripheral and central considerations. J. Man. Manip. Ther. 2011, 19, 223–227. [Google Scholar] [CrossRef]
  3. Simons, D.G. Symptomatology and clinical pathophysiology of myofascial pain. Schmerz 1991, 5, 29–37. [Google Scholar] [CrossRef]
  4. Shushkevich, Y.; Kalichman, L. Myofascial pain in lateral epicondylalgia: A review. J. Bodyw. Mov. Ther. 2013, 17, 434–439. [Google Scholar] [CrossRef]
  5. Kuan, T.S.; Hong, C.Z.; Chen, J.T.; Chen, S.M.; Chien, C.H. The spinal cord connections of the myofascial trigger spots. Eur. J. Pain 2007, 11, 624–634. [Google Scholar] [CrossRef]
  6. Borg-Stein, J.; Iaccarino, M.A. Myofascial pain syndrome treatments. Phys. Med. Rehabil. Clin. N. Am. 2014, 25, 357–374. [Google Scholar] [CrossRef]
  7. Urits, I.; Charipova, K.; Gress, K.; Schaaf, A.L.; Gupta, S.; Kiernan, H.C.; Choi, P.E.; Jung, J.W.; Cornett, E.; Kaye, A.D.; et al. Treatment and management of myofascial pain syndrome. Best Pract. Res. Clin. Anaesthesiol. 2020, 34, 427–448. [Google Scholar] [CrossRef]
  8. Cagnie, B.; Dewitte, V.; Barbe, T.; Timmermans, F.; Delrue, N.; Meeus, M. Physiologic effects of dry needling. Curr. Pain Headache Rep. 2013, 17, 348. [Google Scholar] [CrossRef] [PubMed]
  9. Hong, C.Z.; Simons, D.G. Pathophysiologic and electrophysiologic mechanisms of myofascial trigger points. Arch. Phys. Med. Rehabil. 1998, 79, 863–872. [Google Scholar] [CrossRef] [PubMed]
  10. Chou, L.W.; Hsieh, Y.L.; Kuan, T.S.; Hong, C.Z. Needling therapy for myofascial pain: Recommended technique with multiple rapid needle insertions. Biomedicine 2014, 4, 13. [Google Scholar] [CrossRef] [PubMed]
  11. Fernández-de-las-Peñas, C.; Dommerholt, J. Myofascial trigger points: Peripheral or central phenomenon? Curr. Rheumatol. Rep. 2014, 16, 395. [Google Scholar] [CrossRef] [PubMed]
  12. Malanga, G.A.; Yan, N.; Stark, J. Mechanisms and efficacy of heat and cold therapies for musculoskeletal injury. Postgrad. Med. 2015, 127, 57–65. [Google Scholar] [CrossRef] [PubMed]
  13. Lu, W.; Li, J.; Tian, Y.; Lu, X. Effect of ischemic compression on myofascial pain syndrome: A systematic review and meta-analysis. Chiropr. Man. Therap. 2022, 30, 2–11. [Google Scholar] [CrossRef] [PubMed]
  14. Mense, S. How Do Muscle Lesions such as Latent and Active Trigger Points Influence Central Nociceptive Neurons? J. Musculoskelet. Pain. 2010, 18, 348–353. [Google Scholar] [CrossRef]
  15. Walder, R.Y.; Rasmussen, L.A.; Rainier, J.D.; Light, A.R.; Wemmie, J.A.; Sluka, K.A. ASIC1 and ASIC3 play different roles in the development of Hyperalgesia after inflammatory muscle injury. J. Pain 2010, 11, 210–218. [Google Scholar] [CrossRef] [PubMed]
  16. Wemmie, J.A.; Taugher, R.J.; Kreple, C.J. Acid-sensing ion channels in pain and disease. Nat. Rev. Neurosci. 2013, 14, 461–471. [Google Scholar] [CrossRef] [PubMed]
  17. Lázaro-Navas, I.; Lorenzo-Sánchez-Aguilera, C.; Pecos-Martín, D.; Jiménez-Rejano, J.J.; Navarro-Santana, M.J.; Fernández-Carnero, J.; Gallego-Izquierdo, T. Immediate Effects of Dry Needling on the Autonomic Nervous System and Mechanical Hyperalgesia: A Randomized Controlled Trial. Int. J. Environ. Res. Public Health 2021, 18, 6018. [Google Scholar] [CrossRef] [PubMed]
  18. Fernández-Carnero, J.; Gilarranz-de-Frutos, L.; León-Hernández, J.V.; Pecos-Martin, D.; Alguacil-Diego, I.; Gallego-Izquierdo, T.; Martín-Pintado-Zugasti, A. Effectiveness of Different Deep Dry Needling Dosages in the Treatment of Patients with Cervical Myofascial Pain: A Pilot RCT. Am. J. Phys. Med. Rehabil. 2017, 96, 726–733. [Google Scholar] [CrossRef]
  19. Chys, M.; De Meulemeester, K.; De Greef, I.; Murillo, C.; Kindt, W.; Kouzouz, Y.; Lescroart, B.; Cagnie, B. Clinical Effectiveness of Dry Needling in Patients with Musculoskeletal Pain-An Umbrella Review. J. Clin. Med. 2023, 12, 1205. [Google Scholar] [CrossRef]
  20. Chou, L.W.; Kao, M.J.; Lin, J.G. Probable mechanisms of needling therapies for myofascial pain control. Evid. Based Complement. Alternat. Med. 2012, 2012, 705327. [Google Scholar] [CrossRef]
  21. Hsieh, Y.L.; Yang, S.A.; Yang, C.C.; Chou, L.W. Dry needling at myofascial trigger spots of rabbit skeletal muscles modulates the biochemicals associated with pain, inflammation, and hypoxia. Evid. Based Complement. Alternat. Med. 2012, 2012, 342165. [Google Scholar] [CrossRef]
  22. Korkmaz, M.D.; Medin Ceylan, C. Effect of dry-needling and exercise treatment on myofascial trigger point: A single-blind randomized controlled trial. Complement Ther Clin Pract. 2022, 47, 101571. [Google Scholar] [CrossRef]
  23. Perreault, T.; Dunning, J.; Butts, R. The local twitch response during trigger point dry needling: Is it necessary for successful outcomes? J. Bodyw. Mov. Ther. 2017, 21, 940–947. [Google Scholar] [CrossRef] [PubMed]
  24. Shah, J.P.; Gilliams, E.A. Uncovering the biochemical milieu of myofascial trigger points using in vivo microdialysis: An application of muscle pain concepts to myofascial pain syndrome. J. Bodyw. Mov. Ther. 2008, 12, 371–384. [Google Scholar] [CrossRef] [PubMed]
  25. Myburgh, C.; Hartvigsen, J.; Aagaard, P.; Holsgaard-Larsen, A. Skeletal muscle contractility, self-reported pain and tissue sensitivity in females with neck/shoulder pain and upper Trapezius myofascial trigger points- a randomized intervention study. Chiropr Man Therap. 2012, 20, 36. [Google Scholar] [CrossRef] [PubMed]
  26. León-Hernández, J.V.; Martín-Pintado-Zugasti, A.; Frutos, L.G.; Alguacil-Diego, I.M.; de la Llave-Rincón, A.I.; Fernandez-Carnero, J. Immediate and short-term effects of the combination of dry needling and percutaneous TENS on post-needling soreness in patients with chronic myofascial neck pain. Braz. J. Phys. Ther. 2016, 20, 422–431. [Google Scholar] [CrossRef] [PubMed]
  27. Vorawanthanachai, T. Factors Associated with Immediate Post-needling Soreness after Dry Needling at Upper Trapezius Muscle in Patients with Myofascial Pain syndrome. ASEAN J. Rehabil. Med. 2023, 33, 23–27. [Google Scholar]
  28. Martín-Pintado-Zugasti, A.; Mayoral Del Moral, O.; Gerwin, R.D.; Fernández-Carnero, J. Post-needling soreness after myofascial trigger point dry needling: Current status and future research. J. Bodyw. Mov. Ther. 2018, 22, 941–946. [Google Scholar] [CrossRef]
  29. Cheng, H.T. Spinal cord mechanisms of chronic pain and clinical implications. Curr. Pain Headache Rep. 2010, 14, 213–220. [Google Scholar] [CrossRef]
  30. Comitato, A.; Bardoni, R. Presynaptic Inhibition of Pain and Touch in the Spinal Cord: From Receptors to Circuits. Int. J. Mol. Sci. 2021, 22, 414. [Google Scholar] [CrossRef]
  31. López-Royo, M.P.; Pedersini, P.; Cantero-Téllez, R.; Valdes, K.; Doménech-García, V.; Herrero, P.; Villafañe, J.H. Effects of Ischemic Compression on Trigger Points in the First Dorsal Interosseous Muscle in Patients with Thumb Carpometacarpal Osteoarthritis. Int. J. Environ. Res. Public Health 2021, 18, 2961. [Google Scholar] [CrossRef] [PubMed]
  32. Martín-Pintado Zugasti, A.; Rodríguez-Fernández, Á.L.; García-Muro, F.; López-López, A.; Mayoral, O.; Mesa-Jiménez, J.; Fernández-Carnero, J. Effects of spray and stretch on postneedling soreness and sensitivity after dry needling of a latent myofascial trigger point. Arch. Phys. Med. Rehabil. 2014, 95, 1925–1932.e1. [Google Scholar] [CrossRef] [PubMed]
  33. McCabe, C. Mirror visual feedback therapy. A practical approach. J. Hand Ther. 2011, 24, 170–178. [Google Scholar] [CrossRef] [PubMed]
  34. Rjosk, V.; Kaminski, E.; Hoff, M.; Sehm, B.; Steele, C.J.; Villringer, A.; Ragert, P. Mirror Visual Feedback-Induced Performance Improvement and the Influence of Hand Dominance. Front. Hum. Neurosci. 2016, 9, 702. [Google Scholar] [CrossRef] [PubMed]
  35. Ishihara, Y.; Kodaka, K. Vision-Driven Kinesthetic Illusion in Mirror Visual Feedback. i-Perception 2018, 9, 1–11. [Google Scholar] [CrossRef] [PubMed]
  36. Wu, C.Y.; Huang, P.C.; Chen, Y.T.; Lin, K.C.; Yang, H.W. Effects of mirror therapy on motor and sensory recovery in chronic stroke: A randomized controlled trial. Arch. Phys. Med. Rehabil. 2013, 94, 1023–1030. [Google Scholar] [CrossRef]
  37. Tracey, I.; Mantyh, P.W. The cerebral signature for pain perception and its modulation. Neuron 2007, 55, 377–391. [Google Scholar] [CrossRef]
  38. Thieme, H.; Morkisch, N.; Rietz, C.; Dohle, C.; Borgetto, B. The Efficacy of Movement Representation Techniques for Treatment of Limb Pain--A Systematic Review and Meta-Analysis. J. Pain. 2016, 17, 167–180. [Google Scholar] [CrossRef]
  39. Deconinck, F.J.A.; Smorenburg, A.R.P.; Benham, A.; Ledebt, A.; Feltham, M.G.; Savelsbergh, G.J.P. Reflections on mirror therapy: A systematic review of the effect of mirror visual feedback on the brain. Neurorehabil. Neural. Repair. 2015, 29, 349–361. [Google Scholar] [CrossRef]
  40. Zhang, Y.; Xing, Y.; Li, C.; Hua, Y.; Hu, J.; Wang, Y.; Ya, R.; Meng, Q.; Bai, Y. Mirror therapy for unilateral neglect after stroke: A systematic review. Eur. J. Neurol. 2022, 29, 358–371. [Google Scholar] [CrossRef]
  41. Xie, H.M.; Zhang, K.X.; Wang, S.; Wang, N.; Wang, N.; Li, X.; Huang, L.P. Effectiveness of Mirror Therapy for Phantom Limb Pain: A Systematic Review and Meta-analysis. Arch. Phys. Med. Rehabil. 2022, 103, 988–997. [Google Scholar] [CrossRef] [PubMed]
  42. Ol, H.; Van Heng, Y.; Danielsson, L.; Husum, H. Mirror therapy for phantom limb and stump pain: A randomized controlled clinical trial in landmine amputees in Cambodia. Scand. J. Pain 2018, 18, 603–610. [Google Scholar] [CrossRef] [PubMed]
  43. Turner, L.; Shamseer, L.; Altman, D.G.; Weeks, L.; Peters, J.; Kober, T.; Dias, S.; Schulz, K.F.; Plint, A.C.; Moher, D. Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published in medical journals. Cochrane Database Syst. Rev. 2012, 11, MR000030. [Google Scholar] [CrossRef]
  44. Faul, F.; Erdfelder, E.; Lang, A.G.; Buchner, A. G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav. Res. Methods 2007, 39, 175–191. [Google Scholar] [CrossRef]
  45. Lee, J.S.; Hobden, E.; Stiell, I.G.; Wells, G.A. Clinically important change in the visual analog scale after adequate pain control. Acad. Emerg. Med. 2003, 10, 1128–1130. [Google Scholar] [CrossRef]
  46. Liu, Y.; Lin, L.; Xiong, Q.; Zeng, W.; Yu, L.; Hou, Y. Effect of mirror therapy on recovery of stroke survivors: A systematic review and network meta-analysis. Neurosci. Lett. 2018, 662, 292–300. [Google Scholar] [CrossRef]
  47. Mirela Cristina, L.; Matei, D.; Ignat, B.; Popescu, C.D. Mirror therapy enhances upper extremity motor recovery in stroke patients. Acta Neurol Belg. 2015, 15, 597–603. [Google Scholar] [CrossRef]
  48. Mulder, T. Motor imagery and action observation: Cognitive tools for rehabilitation. J. Neural. Transm. 2007, 114, 1265–1278. [Google Scholar] [CrossRef]
  49. Garry, M.I.; Loftus, A.; Summers, J.J. Mirror, mirror on the wall: Viewing a mirror reflection of unilateral hand movements facilitates ipsilateral M1 excitability. Exp. Brain Res. 2005, 163, 118–122. [Google Scholar] [CrossRef] [PubMed]
  50. Matsumoto, T.; Watanabe, T.; Kuwabara, T.; Yunoki, K.; Chen, X.; Kubo, N.; Kirimoto, H. Excitability of the Ipsilateral Primary Motor Cortex During Unilateral Goal-Directed Movement. Front. Hum. Neurosci. 2021, 15, 617146. [Google Scholar] [CrossRef] [PubMed]
  51. Volz, M.S.; Suarez-Contreras, V.; Portilla, A.L.S.; Illigens, B.; Bermpohl, F.; Fregni, F. Movement observation-induced modulation of pain perception and motor cortex excitability. Clin. Neurophysiol. 2015, 126, 1204–1211. [Google Scholar] [CrossRef] [PubMed]
  52. Vidor, L.P.; Torres, I.L.; Medeiros, L.F.; Dussán-Sarria, J.A.; Dall’agnol, L.; Deitos, A.; Brietzke, A.; Laste, G.; Rozisky, J.R.; Fregni, F.; et al. Association of anxiety with intracortical inhibition and descending pain modulation in chronic myofascial pain syndrome. BMC Neurosci. 2014, 15, 42. [Google Scholar] [CrossRef] [PubMed]
  53. Iwanami, J.; Mutai, H.; Sagari, A.; Sato, M.; Kobayashi, M. Relationship between Corticospinal Excitability While Gazing at the Mirror and Motor Imagery Ability. Brain Sci. 2023, 13, 463. [Google Scholar] [CrossRef] [PubMed]
  54. Do, A.T.L.; Enax-Krumova, E.K.; Özgül, Ö.; Eitner, L.B.; Heba, S.; Tegenthoff, M.; Maier, C.; Höffken, O. Distraction by a cognitive task has a higher impact on electrophysiological measures compared with conditioned pain modulation. BMC Neurosci. 2020, 21, 53. [Google Scholar] [CrossRef] [PubMed]
  55. Petrovic, P.; Petersson, K.M.; Ghatan, P.H.; Stone-Elander, S.; Ingvar, M. Pain-related cerebral activation is altered by a distracting cognitive task. Pain 2000, 85, 19–30. [Google Scholar] [CrossRef] [PubMed]
  56. Moont, R.; Pud, D.; Sprecher, E.; Sharvit, G.; Yarnitsky, D. ‘Pain inhibits pain’ mechanisms: Is pain modulation simply due to distraction? Pain 2010, 150, 113–120. [Google Scholar] [CrossRef]
  57. Asefi Rad, A.; Wippert, P.M. Insights into pain distraction and the impact of pain catastrophizing on pain perception during different types of distraction tasks. Front. Pain Res. 2024, 5, 1266974. [Google Scholar] [CrossRef]
  58. Bisio, A.; Biggio, M.; Avanzino, L.; Ruggeri, P.; Bove, M. Kinaesthetic illusion shapes the cortical plasticity evoked by action observation. J. Physiol. 2019, 597, 3233–3245. [Google Scholar] [CrossRef]
  59. Bello, U.M.; Kranz, G.S.; Winser, S.J.; Chan, C.C.H. Neural Processes Underlying Mirror-Induced Visual Illusion: An Activation Likelihood Estimation Meta-Analysis. Front. Hum. Neurosci. 2020, 14, 276. [Google Scholar] [CrossRef]
  60. Puledda, F.; Bruchhage, M.; O’Daly, O.; Ffytche, D.; Williams, S.C.R.; Goadsby, P.J. Occipital cortex and cerebellum gray matter changes in visual snow syndrome. Neurology 2020, 95, e1792–e1799. [Google Scholar] [CrossRef]
  61. Lee, J.; Ahn, S.W.; Wachholtz, A.; Lee, J.H. Attentional Patterns Toward Pain-Related Information: Comparison Between Chronic Pain Patients and Non-pain Control Group. Front. Psychol. 2020, 11, 1990. [Google Scholar] [CrossRef] [PubMed]
  62. Ruf, S.P.; Hetterich, L.; Mazurak, N.; Rometsch, C.; Jurjut, A.M.; Ott, S.; Herrmann-Werner, A.; Zipfel, S.; Stengel, A. Mirror Therapy in Patients with Somatoform Pain Disorders—A Pilot Study. Behav. Sci. 2023, 13, 432. [Google Scholar] [CrossRef] [PubMed]
  63. Samuelkamaleshkumar, S.; Reethajanetsureka, S.; Pauljebaraj, P.; Benshamir, B.; Padankatti, S.M.; David, J.A. Mirror therapy enhances motor performance in the paretic upper limb after stroke: A pilot randomized controlled trial. Arch. Phys. Med. Rehabil. 2014, 95, 2000–2005. [Google Scholar] [CrossRef] [PubMed]
  64. Koenigs, M.; Barbey, A.K.; Postle, B.R.; Grafman, J. Superior parietal cortex is critical for the manipulation of information in working memory. J. Neurosci. 2009, 29, 14980–14986. [Google Scholar] [CrossRef]
  65. Balslev, D.; Cole, J.; Miall, R.C. Proprioception contributes to the sense of agency during visual observation of hand movements: Evidence from temporal judgments of action. J. Cogn. Neurosci. 2007, 19, 1535–1541. [Google Scholar] [CrossRef]
  66. Imaizumi, S.; Asai, T.; Koyama, S. Agency over Phantom Limb Enhanced by Short-Term Mirror Therapy. Front. Hum. Neurosci. 2017, 11, 483. [Google Scholar] [CrossRef]
  67. Ben Shalom, D. The amygdala-insula-medial prefrontal cortex-lateral prefrontal cortex pathway and its disorders. Front. Neuroanat. 2022, 16, 1028546. [Google Scholar] [CrossRef]
  68. Ferrari, C.; Lega, C.; Vernice, M.; Tamietto, M.; Mende-Siedlecki, P.; Vecchi, T.; Todorov, A.; Cattaneo, Z. The Dorsomedial Prefrontal Cortex Plays a Causal Role in Integrating Social Impressions from Faces and Verbal Descriptions. Cereb. Cortex. 2016, 26, 156–165. [Google Scholar] [CrossRef]
  69. Powers, K.E.; Chavez, R.S.; Heatherton, T.F. Individual differences in response of dorsomedial prefrontal cortex predict daily social behavior. Soc. Cogn. Affect. Neurosci. 2016, 11, 121–126. [Google Scholar] [CrossRef]
  70. Michielsen, M.E.; Selles, R.W.; van der Geest, J.N.; Eckhardt, M.; Yavuzer, G.; Stam, H.J.; Smits, M.; Ribbers, G.M.; Bussmann, J.B. Motor recovery and cortical reorganization after mirror therapy in chronic stroke patients: A phase II randomized controlled trial. Neurorehabil. Neural. Repair. 2011, 25, 223–233. [Google Scholar] [CrossRef]
  71. Canlı, K.; Van Oijen, J.; Van Oosterwijck, J.; Meeus, M.; Van Oosterwijck, S.; De Meulemeester, K. Influence of Sensory Re-training on Cortical Reorganization in Peripheral Neuropathy: A Systematic Review. PM&R, 2023; online ahead of print. [Google Scholar] [CrossRef]
Figure 1. CONSORT flow diagram. Flowchart showing enrollment, allocation, follow-up and analysis throughout the study.
Figure 1. CONSORT flow diagram. Flowchart showing enrollment, allocation, follow-up and analysis throughout the study.
Jcm 13 01490 g001
Figure 2. Intervention. Both groups received a comprehensive treatment regimen consisting of (A) Deep Dry Needling, (B) Ischemic Compression, (C) Cold Spray application, and (D) Stretching exercises.
Figure 2. Intervention. Both groups received a comprehensive treatment regimen consisting of (A) Deep Dry Needling, (B) Ischemic Compression, (C) Cold Spray application, and (D) Stretching exercises.
Jcm 13 01490 g002
Figure 3. Intervention. Mirror Visual Feedback Therapy programme implemented for the experimental group. In the MVF Observation Phase for MTrPS Lateral Elbow Pain, specific muscle functions were targeted, including (A) hand opening, (B) hand closing, (C) wrist extension, and (D) wrist flexion.
Figure 3. Intervention. Mirror Visual Feedback Therapy programme implemented for the experimental group. In the MVF Observation Phase for MTrPS Lateral Elbow Pain, specific muscle functions were targeted, including (A) hand opening, (B) hand closing, (C) wrist extension, and (D) wrist flexion.
Jcm 13 01490 g003
Figure 4. Intergroup differences between EG vs. CG after intervention. Significant reduction in post-needling pain intensity (VAS 0-10) (p = 0.034) was observed in individuals treated with MVF compared to those who were not, indicating a shift towards lower pain levels. Additionally, a notable group difference was observed in post-TPDT (mm) (p = 0.079) values, with substantial reduction in values among EG participants. However, post-PPT (Kg/cm2) and post-MHGS (Kg/F) values showed non-significant differences between groups (p = 0.862, p = 0.905, respectively).
Figure 4. Intergroup differences between EG vs. CG after intervention. Significant reduction in post-needling pain intensity (VAS 0-10) (p = 0.034) was observed in individuals treated with MVF compared to those who were not, indicating a shift towards lower pain levels. Additionally, a notable group difference was observed in post-TPDT (mm) (p = 0.079) values, with substantial reduction in values among EG participants. However, post-PPT (Kg/cm2) and post-MHGS (Kg/F) values showed non-significant differences between groups (p = 0.862, p = 0.905, respectively).
Jcm 13 01490 g004aJcm 13 01490 g004b
Table 1. Demographic description of the sample.
Table 1. Demographic description of the sample.
OutcomesGroupMeanSDT-Studentp
Age (years)EG24.910.9
CG24.99.5−0.0020.998
Weight (Kg)EG75.85.7
CG73.410.60.6290.538
Height (m)EG1.770.06
CG1.720.081.2610.224
BMI (Kg/m2)EG24.31.7
CG24.73.5−0.3370.740
Note: BMI: body mass index. T-student tests for independent samples were carried out.
Table 2. Description of study variables.
Table 2. Description of study variables.
OutcomesGroupMeanSDShapiro–Wilk Wp
Pre-Pain intensityEG1.4161.2690.8980.017 **
(VAS 0-10)CG1.1500.9550.8610.004 **
Post-Pain intensityEG1.0640.9340.8570.002 **
(VAS 0-10)CG1.6331.0250.9270.085
Pre-PPTEG1.9090.6720.9110.033 *
(Kg/cm2)CG1.6400.6830.8620.004 **
Post-PPTEG1.7460.6130.9380.135
(Kg/cm2)CG1.5740.7290.8950.017
Pre-TPDTEG9.3205.8720.826<0.001 ***
(mm)CG13.5006.8710.9470.232
Post-TPDTEG9.6406.5440.8400.001 **
(mm)CG12.0836.2130.9030.025 **
Pre-MHGSEG37.968.0320.9110.033 *
(Kg/F)CG34.047.3860.9240.073
Post-MHGSEG37.7127.9860.9280.077
(Kg/F)CG34.8677.6090.9440.204
Note: MHGS: maximum hand grip strength, PPT: pain pressure threshold, TPDT: two-point discrimination threshold, VAS: visual analogue scale. Shapiro–Wilk goodness-of-fit test was considered statistically different (*) p < 0.05, (**) p < 0.01, (***) p < 0.001.
Table 3. Intra-group differences of the experimental group.
Table 3. Intra-group differences of the experimental group.
CI [95%] ES
OutcomesTestStatisticpMDSEMInf.Sup.Rank–Biserial
Pain intensity
(VAS 0-10)
Wilcoxon W137.000.047 *0.4000.2710.000Inf.0.442
PPT (Kg/cm2)Wilcoxon W262.00<0.001 ***0.1480.0380.071Inf.0.747
TPDT (mm)Wilcoxon W121.000.711−0.0000.674−1.500Inf.−0.127
MHGS (Kg/F)Wilcoxon W177.000.2240.2000.199−0.150Inf.0.180
Note: MHGS: maximum hand grip strength, PPT: pain pressure threshold, TPDT: two-point discrimination threshold, VAS: visual analogue scale. Statistically differences were considered (*) p < 0.05, (***) p < 0.001.
Table 4. Intra-group differences of the control group.
Table 4. Intra-group differences of the control group.
CI [95%] ES
OutcomesTestStatisticpMDSEMInf.Sup.Rank–Biserial
Pain intensityWilcoxon W105.500.643−0.4000.247−0.899−Inf.−0.086
(VAS 0-10)
PPT (Kg/cm2)Wilcoxon W163.000.6480.0290.073−Inf.0.1660.086
TPDT (mm)Wilcoxon W207.000.9831.9991.047−Inf.3.0000.496
MHGS (Kg/F)Wilcoxon W83.000.081−0.7991.051−Inf.0.200−0.343
Note: MHGS: maximum hand grip strength, PPT: pain pressure threshold, TPDT: two-point discrimination threshold, VAS: Visual Analogue Scale.
Table 5. Intergroup differences.
Table 5. Intergroup differences.
ES
OutcomesTestStatisticpRank–Biserial CorrelationRank–Biserial
Correlation
Pain intensity
(VAS 0-10)
Mann–Whitney U188.0000.034 *−0.3730.165
Post-PPT (Kg/cm2)Mann–Whitney U354.0000.8620.1800.165
Post-TPDT (mm)Mann–Whitney U212.0000.079−0.2930.165
Post-MHGS (Kg/F)Mann–Whitney U365.0000.9050.2170.165
Note: MHGS: maximum hand grip strength, PPT: pain pressure threshold, TPDT: two-point discrimination threshold, VAS: Visual Analogue Scale. Mann–Whitney U test was used for statistical differences (*) p < 0.05. Location parameters were obtained using the Hodges–Lehmann Estimate. Size effect was calculated using the point–biserial correlation coefficient.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Martín Pérez, S.E.; Rodríguez, J.D.; Kalitovics, A.; de Miguel Rodríguez, P.; Bortolussi Cegarra, D.S.; Rodríguez Villanueva, I.; García Molina, Á.; Ruiz Rodríguez, I.; Montaño Ocaña, J.; Martín Pérez, I.M.; et al. Effect of Mirror Therapy on Post-Needling Pain Following Deep Dry Needling of Myofascial Trigger Point in Lateral Elbow Pain: Prospective Controlled Pilot Trial. J. Clin. Med. 2024, 13, 1490. https://doi.org/10.3390/jcm13051490

AMA Style

Martín Pérez SE, Rodríguez JD, Kalitovics A, de Miguel Rodríguez P, Bortolussi Cegarra DS, Rodríguez Villanueva I, García Molina Á, Ruiz Rodríguez I, Montaño Ocaña J, Martín Pérez IM, et al. Effect of Mirror Therapy on Post-Needling Pain Following Deep Dry Needling of Myofascial Trigger Point in Lateral Elbow Pain: Prospective Controlled Pilot Trial. Journal of Clinical Medicine. 2024; 13(5):1490. https://doi.org/10.3390/jcm13051490

Chicago/Turabian Style

Martín Pérez, Sebastián Eustaquio, Jhoselyn Delgado Rodríguez, Alejandro Kalitovics, Pablo de Miguel Rodríguez, Daniela Sabrina Bortolussi Cegarra, Iremar Rodríguez Villanueva, Álvaro García Molina, Iván Ruiz Rodríguez, Juan Montaño Ocaña, Isidro Miguel Martín Pérez, and et al. 2024. "Effect of Mirror Therapy on Post-Needling Pain Following Deep Dry Needling of Myofascial Trigger Point in Lateral Elbow Pain: Prospective Controlled Pilot Trial" Journal of Clinical Medicine 13, no. 5: 1490. https://doi.org/10.3390/jcm13051490

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop